Arulkumaran Rithvik
Vellore, TN, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Targeting the synovial engine: next-generation engineered immune cells to eradicate pathogenic FLS in rheumatoid arthritis, with safety-first, selective designs.
Journal: Frontiers in immunology
Published: May 25, 2026
Majoon Ushba alleviated IL-17A sensitized keratinocyte ferroptosis via JAK-2-STAT-3 signaling axis and reversed imiquimod induced psoriasiform inflammation.
Journal: Pharmaceutical biology
Published: April 13, 2026
Fibroblast growth factor 2 in the hotbed of rheumatoid arthritis pathogenesis.
Journal: International immunopharmacology
Published: July 25, 2025
Psoriasis Relapse: Exploring the Role of Epigenetics, Metabolic Reprogramming, and Inflammatory Memory.
Journal: Immunological investigations
Published: June 19, 2025
Decoding poly (RC)-binding protein 1 (PCBP1), the underrated guard at the foothill of ferroptosis.
Journal: Pathology, research and practice
Published: October 12, 2024
IL-17A/IL-17RA interaction blockade sensitizes synovial macrophages to efferocytosis and PD-L1 signaling via rewiring STAT-3/ADAM17/MERTK axis in rheumatoid arthritis animal model.
Journal: International immunopharmacology
Published: February 20, 2024
3,3'-Diindolylmethane inhibits Th17 cell differentiation via impairing IRF-7-mediated plasmacytoid dendritic cell activation in imiquimod-induced psoriasis mice.
Journal: In vitro cellular & developmental biology. Animal
Published: December 04, 2023
Unleashing the pathological imprinting of cancer in autoimmunity: Is ZEB1 the answer?
Journal: Life sciences
Published: June 30, 2023
Showing 1-10 of 10
Last Updated: 09/26/2026